STRATAGEM COST Action 17104

New diagnostic and therapeutic tools
against multidrug resistant tumours

4th Annual Conference New diagnostic and therapeutic tools
against multidrug resistant tumours

Training School “Targeting MDR Tumours: from natural product chemistry to nanocarrier-based formulation”

We aim to improve both
the diagnosis and therapy
of multidrug resistant (MDR)
solid tumours.

Welcome!

STRATAGEM contributes to Covid-19 research

Fighting together
against multidrug
resistant tumours

Special
issues
edited by
our scientists

Working
Group 1

Identification of new biomarkers and therapeutic targets for MDR tumours

Working
Group 2

Synthesis and nanodelivery strategies for new therapeutic tools against MDR tumours

Working
Group 3

Efficacy validation of new therapeutic tools against pre-clinical models of MDR tumours

Working
Group 4

Pharmacokinetics and ADMET of the new therapeutic tools; safety of the targets

Events / News

Special Issue “In Silico Activity Profiling of Natural Products”

2021-07-14

Guest Editors are STRATAGEM members Prof. Ilza Pajeva ( pajeva@biomed.bas.bg), from the Department of QSAR and Molecular Modelling, Institute of…

Early Career Investigators (ECIs) were awarded ITC Conference Grants and won Best Presentation Awards

2021-07-12

Dr. Hugo R. Caires, Dr. Diana Sousa, and Dr. Verónica Bastos were awarded Inclusiveness Target Countries (ITC) Conference Grants. Dr….

Training School “Targeting MDR Tumours: from natural product chemistry to nanocarrier-based formulation”

2021-05-18

Organized by researchers of COST STRATAGEM WG2 (New therapeutic tools against MDR & Nanodelivery of the therapeutic tools) this summer…